Inergetics Stock Poised for Gains

Millennium Biotechnologies Inc. (MBTG.OB) is taking on a new name, Inergetics, and ticker symbol, which will likely send stock values rising, according to M.E. Garza, writing for BioMed Reports. Garza spoke with the companys president, Mark C. Mirken, about opportunities ahead for the company, which focuses on the sports nutrition market. For example, Garza said a major bottling company is rumored to be close to investing in Millennium Biotech to help market its Surgex sports drink line as a competitor to Muscle Milk, recently purchased by PepsiCo for $600 million.

Mirken said the Surgex product was developed in concert with strength and conditioning coaches in the NBA and NFL, and is scientifically validated for its ability to improve strength and performance. He also told Garza the company is preparing to announce a significant commercial debut of the Surgex product in a powdered drink format, followed by its evolution into a ready-to-drink functional beverage format in the next two to three months. Rutgers University has released two articles about Surgexs ability to increase recovery time in athletes.

The company is also looking at opportunities for its Resurgex product, which was launched originally in calorie balanced (Essential) and calorie intense (Essential Plus) formats. Mirken commented, We have a long way to go to fulfill that product portfolio. There are opportunities for us in long term care, in diabetics, in gluten-free products, and more. So we are working on filling out our portfolio there. Inergetics also is promoting products in the oncology and immunocompromised market, with its Resurgex Select oncology functional beverage going into trials soon.

Garza quoted Mirken on the companys bright future: As you step back and look at us, we are a company that has at least three engines: one in oncology and immunocompromised, going into trials and one in long term care and assisted living. We recently announced a relationship with a billion dollar pharmaceutical company which is expanding our reach into the long-term care space. Finally, the third product is the sports product, which is about to be commercialized. We are, as a company, at the beginning of our commercialization era and we expect some significant success, certainly within the next quarter or two.